Universität zu Köln

Article

Özel, Cem ORCID: 0009-0006-7091-7027, Abualia, Khawla ORCID: 0000-0002-7534-4014, Nguyen-Minh, Duc, Matin, Mahsa ORCID: 0000-0001-7954-6863, Unnersjö-Jess, David ORCID: 0000-0002-4162-0973, Höhne, Martin ORCID: 0000-0001-8698-5389, Bloch, Wilhelm, Hagmann, Henning ORCID: 0000-0002-2624-2740, Coward, Richard J.M., Brähler, Sebastian, Schermer, Bernhard ORCID: 0000-0002-5194-9000, Benzing, Thomas ORCID: 0000-0003-0512-1066, Antczak, Philipp ORCID: 0000-0001-9600-7757 and Brinkkötter, Paul T. ORCID: 0000-0002-4287-2080 (2026). Mitochondrial integrity modulates mTOR signaling and podocyte function. iScience, 29 (1). pp. 1-19. Elsevier. ISSN 2589-0042

Özel, Cem ORCID: 0009-0006-7091-7027, Reitmeier, Katrin M. ORCID: 0009-0003-8534-520X, Kieckhöfer, Emilia ORCID: 0009-0004-7888-9185, Abualia, Khawla ORCID: 0000-0002-7534-4014, Nguyen‐Minh, Duc, Matin, Mahsa ORCID: 0000-0001-7954-6863, Hagmann, Henning ORCID: 0000-0002-2624-2740, Coward, Richard J. M. ORCID: 0000-0001-6183-2546, Brähler, Sebastian, Antczak, Philipp ORCID: 0000-0001-9600-7757, Schermer, Bernhard ORCID: 0000-0002-5194-9000, Benzing, Thomas ORCID: 0000-0003-0512-1066, Giavalisco, Patrick ORCID: 0000-0002-4636-1827 and Brinkkoetter, Paul T. ORCID: 0000-0002-4287-2080 (2025). Disruption of Mitochondrial Dynamics and Integrity Drives Divergent Metabolic Flexibility and Resilience in Podocytes. The FASEB Journal, 39 (24). pp. 1-18. Wiley. ISSN 0892-6638

Lindemann, Christoph Heinrich ORCID: 0000-0001-5966-3018, Burst, Volker ORCID: 0000-0002-0256-6628, Völker, Linus Alexander ORCID: 0000-0002-4461-6128, Brähler, Sebastian, Simic, Dusan ORCID: 0000-0002-7325-9481, Becker, Ingrid ORCID: 0000-0001-5829-3553, Hellmich, Martin ORCID: 0000-0001-5174-928X, Kurscheid, Clarissa, Scholten, Nadine ORCID: 0000-0002-7793-7745, Krauspe, Ruben, Leibel, Kerstin ORCID: 0009-0008-5234-4856, Stock, Stephanie ORCID: 0000-0002-1726-9300 and Brinkkoetter, Paul Thomas ORCID: 0000-0002-4287-2080 (2024). Personalized, interdisciplinary patient pathway for cross-sector care of multimorbid patients (eliPfad trial): study protocol for a randomized controlled trial. Trials, 25 (1). pp. 1-16. Springer Nature. ISSN 1745-6215

Schömig, Thomas ORCID: 0009-0001-7560-4285, Diefenhardt, Paul ORCID: 0000-0003-3982-8983, Plagmann, Ingo ORCID: 0000-0003-0263-7040, Trinsch, Bastian ORCID: 0000-0003-4435-3214, Merz, Tim, Crispatzu, Giuliano ORCID: 0000-0001-8041-2125, Unnersjö-Jess, David ORCID: 0000-0002-4162-0973, Nies, Jasper ORCID: 0000-0003-3751-4008, Pütz, David, Sierra Gonzalez, Claudio ORCID: 0000-0002-8458-0377, Schermer, Bernhard ORCID: 0000-0002-5194-9000, Benzing, Thomas ORCID: 0000-0003-0512-1066, Brinkkoetter, Paul Thomas ORCID: 0000-0002-4287-2080 and Brähler, Sebastian ORCID: 0000-0002-7685-5780 (2024). The podocytes’ inflammatory responses in experimental GN are independent of canonical MYD88-dependent toll-like receptor signaling. Scientific Reports, 14 (1). pp. 1-12. Springer Nature. ISSN 2045-2322

Osterholt, Thomas ORCID: 0000-0001-5047-0252, Todorova, Polina Georgieva ORCID: 0000-0002-4728-224X, Kühne, Lucas ORCID: 0000-0002-5990-0279, Ehren, Rasmus ORCID: 0000-0002-3245-7481, Weber, Lutz T. ORCID: 0000-0003-4116-598X, Grundmann, Franziska ORCID: 0000-0002-5766-7477, Benzing, Thomas ORCID: 0000-0003-0512-1066, Brinkkötter, Paul T. ORCID: 0000-0002-4287-2080 and Völker, Linus A. ORCID: 0000-0002-4461-6128 (2023). Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS. Scientific Reports, 13 (1). p. 6980. Springer Nature. ISSN 2045-2322

Kühne, Lucas ORCID: 0000-0002-5990-0279, Völker, Linus A. ORCID: 0000-0002-4461-6128, Hagmann, Henning ORCID: 0000-0002-2624-2740, Hägele, Holger, Osterholt, Thomas ORCID: 0000-0001-5047-0252, Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Thomas, Andreas, Breuer, Johanna, Grüttner, Berthold, Gottschalk, Ingo, Kann, Martin, Benzing, Thomas ORCID: 0000-0003-0512-1066, Thevis, Mario, Müller, Annette M. and Brinkkötter, Paul T. ORCID: 0000-0002-4287-2080 (2022). First use of the anti‐VWF nanobody caplacizumab to treat iTTP in pregnancy. British Journal of Haematology, 196 (3). e30-e33. Wiley-Blackwell. ISSN 0007-1048